FilippiMRoccaMACiccarelliO, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol2016; 15: 292–303.
2.
TintoreMRoviraARioJ, et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain2015; 138: 1863–1874.
3.
TintoreMRoviraARioJ, et al. Is optic neuritis more benign than other first attacks in multiple sclerosis?Ann Neurol2005; 57: 210–215.
4.
RoccaMAHickmanSJBoL, et al. Imaging the optic nerve in multiple sclerosis. Mult Scler2005; 11: 537–541.
5.
PetzoldAWattjesMPCostelloF, et al. The investigation of acute optic neuritis: A review and proposed protocol. Nat Rev Neurol2014; 10: 447–458.
6.
BermelRABalcerLJ.Optic neuritis and the evaluation of visual impairment in multiple sclerosis. Continuum2013; 19: 1074–1086.
7.
RizzoJF3rdAndreoliCMRabinovJD.Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology2002; 109: 1679–1684.
GronsethGSAshmanEJ.Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology2000; 54: 1720–1725.
10.
MealyMAWhetstoneAOrmanG, et al. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci2015; 355: 59–63.
